<DOC>
	<DOCNO>NCT01387191</DOCNO>
	<brief_summary>The objective study evaluate incidence adverse event Japanese pulmonary arterial hypertension subject treat epoprostenol injection base prescribe information condition general clinical practice also grasp follow item ; 1 . Unknown adverse reaction ( especially , significant adverse reaction ) 2 . Adverse reaction onset status practical drug use condition 3 . Factors possibly influential safety 4 . Factors possibly influential efficacy 5 . Patient 's prognosis , efficacy safety long-term use</brief_summary>
	<brief_title>Drug Use Investigation FLOLAN ( Epoprostenol ) Injection 0.5mgãƒ»1.5mg</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>Subjects cardiovascular disease Subjects hypersensitivity epoprostenol Subjects right cardiac failure acute exacerbation Subjects severe leave ventricular systolic dysfunction Subjects serious leave ventricular dysfunction Subjects whose pulmonary edema get bad dose initiation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>